Kairos PharmaKAPA
13F holders, Q4 2025 (December 31)14holders
5new positions
5sold out
1famous investor
$0.71avg. 13F price*
At the end of Q4 2025, 14 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings, unchanged from Q3 2025. 5 opened new positions and 5 sold out. The largest holders were Citadel Advisors ($228K), Vanguard Group Inc. ($94K) and Two Sigma Investments, LP ($67K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $277K |
| Exits | 5 | $82K |
All 13F filers, Q3 2025 → Q4 2025: 482,860 shares bought and 72,161 shares sold, net +410,699 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Citadel Advisors | 0.00% | New | 321,738 | $228K |
| Vanguard Group Inc. | 0.00% | No change | 131,828 | $94K |
| Two Sigma Investments, LP | 0.00% | Add +105.3% | 94,008 | $67K |
| Geode Capital Management, LLC | 0.00% | Add +10.7% | 72,833 | $52K |
| XTX Topco Ltd | 0.00% | Add +290.8% | 48,494 | $34K |
| SevenBridge Financial Group, LLC | 0.01% | No change | 44,286 | $32K |
| Aptus Capital Advisors, LLC | 0.00% | No change | 44,286 | $31K |
| State Street Corp. | 0.00% | No change | 24,100 | $17K |
| HRT Financial LP | 0.00% | New | 21,319 | $15K |
| Virtu Financial LLC | 0.00% | New | 20,278 | $14K |
| Two Sigma Advisers, LP | 0.00% | New | 15,142 | $11K |
| Osaic Holdings, Inc. | 0.00% | New | 13,045 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -29.0% | 4,227 | $3K |
| Bank of America Corp. | 0.00% | Reduce -55.9% | 134 | $95 |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.